Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Address
399 BINNEY STREET
CAMBRIDGE, MA 02139
Founded
2015
Number of Employees
323
Website
http://www.relaytx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)